ertapenem + levofloxacin + metronidazole

This is a combination of three antibiotics—ertapenem, levofloxacin, and metronidazole—used together for the treatment of severe or complicated infections, particularly intra-abdominal infections. - **Ertapenem** is a carbapenem antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. It has broad-spectrum activity against Gram-positive and Gram-negative bacteria but limited activity against non-fermenters like Pseudomonas aeruginosa[4][8]. - **Levofloxacin** is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination. It covers many Gram-negative and some Gram-positive organisms[5]. - **Metronidazole** is an antibiotic effective primarily against anaerobic bacteria and certain protozoa; it disrupts DNA synthesis in susceptible organisms by forming toxic metabolites. The combination targets both aerobic (including Enterobacteriaceae) and anaerobic pathogens (such as Bacteroides fragilis), making it suitable for polymicrobial infections like complicated intra-abdominal infections or appendicitis[1][3][7]. This regimen may be used when monotherapy with a single agent does not provide adequate coverage or in cases where resistance patterns necessitate broader spectrum therapy.